# Mesenchymal Stem Cells (MSCs) and Conditioned Medium Mesenchymal Stem Cells as Adjuvant Therapy for Sepsis

> **NCT07439848** · PHASE1,PHASE2 · RECRUITING · sponsor: **PT. Prodia Stem Cell Indonesia** · enrollment: 15 (estimated)

## Conditions studied

- Acute Respiratory Distress Syndrome

## Interventions

- **OTHER:** Control (NaCl 0.9%)
- **BIOLOGICAL:** UC-MSC
- **BIOLOGICAL:** UC-MSC and Secretome

## Key facts

- **NCT ID:** NCT07439848
- **Lead sponsor:** PT. Prodia Stem Cell Indonesia
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-25
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07439848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07439848, "Mesenchymal Stem Cells (MSCs) and Conditioned Medium Mesenchymal Stem Cells as Adjuvant Therapy for Sepsis". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT07439848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*